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Abstract
Introduction: Toxic epidermal necrolysis is a rare exfoliative disorder with a high mortality rate.
Case presentation: We present a 70-year-old woman of Iranian descent who presented with
toxic epidermal necrolysis that was initially diagnosed as a scald burn. Further anamnesis prompted
by spread of the lesions during hospitalization revealed that the patient had been receiving
ceftriaxone for several days. To the best of our knowledge, this is the first case of ceftriaxone-
induced toxic epidermal necrolysis in the English literature.
Conclusion: Toxic epidermal necrolysis is an acute, life-threatening, exfoliative disorder with a
high mortality rate. High clinical suspicion, prompt recognition, and initiation of supportive care is
mandatory. Thorough investigation of the pathogenetic mechanisms is fundamental. Optimal
treatment guidelines are still unavailable.
Introduction
Toxic epidermal necrolysis(TEN) is a rare, potentially life-
threatening disorder characterized by widespread epider-
mal death [1,2]. The majority of reported cases were the
result of idiosyncratic drug reactions [3]. The severity of
the syndrome, the anecdotal case reports, and the uncon-
trolled series presented in the English literature render
accurate characterization of the syndrome difficult in
terms of underlying pathogenic mechanisms and ade-
quate treatment options.
We present a case of TEN diagnosed initially as a scald
burn. The similar initial dermatological manifestations of
these entities might be confusing to the clinician, espe-
cially when the patient is disoriented and an accurate
anamnesis is difficult to obtain.
In the present case, TEN was caused by ceftriaxone ther-
apy. To the best of our knowledge, this is the first case of
ceftriaxone-induced TEN in the English literature.
Case presentation
A 70-year-old woman of Iranian descent was referred to
our trauma unit for a major scald burn. The exact mecha-
nism of injury was inconclusive. The patient had a history
of diabetes mellitus type 2, ischemic heart disease, hyper-
tension, hyperparathyroidism, hyperlipidemia, chronic
bronchitis, glaucoma, and mild depressive disorder. She
had been receiving treatment on a regular basis with the
following medications: amitriptyline, enalapril, glybu-
ride, verapamil, omeprazole, aspirin, simvastatin, theo-
phylline, furosemide, metformin, citropram,
dorzolamide hydrochloride eye drops, and latanoprost
eye drops.
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On admission, the patient was disoriented. Blood pres-
sure was 90/60 mmHg. Cutaneous examination revealed
a second-degree superficial burn involving both breasts,
lateral aspect of the flanks, anteromedial aspect of the
arms, medial aspect of the thighs, and the right scapular
region. Diffuse erythema was noted, especially of the
upper extremity and anterior trunk (Figs. 1,2).
A presumptive diagnosis of a second-degree, superficial
major scald burn affecting 26% of the total body surface
area (TBSA) was made. Fluid resuscitation was initiated
according to the Parkland formula [4]. A Foley catheter
was inserted. Local treatment included wound debride-
ment and application of saline-soaked gauze.
Physician examination 12 hours post-admission to the
Burn Unit was remarkable for thin blisters in locations not
affected on admission: back, neck, inguinal region, and
both knees (Figs. 1, 2), ultimately effecting 35% of the
TBSA. The worsened epidermolysis was accompanied by a
positive Nikolsky sign.
On further questioning, burn was ruled out as a causal fac-
tor. The patient reported that 2 days prior to admission,
she had been discharged from another hospital with a
diagnosis of pneumonia, and she had been receiving
ceftriaxone for 4 days.
The final diagnosis was TEN due to ceftriaxone intake. The
mucous membranes were not involved. Treatment with
intravenous hydrocortisone 500 mg was initiated. The
hypoglycemia (glucose level-45 mg/dl) was successfully
treated with intravenous dextrose 5%, and the oral
hypoglycemic medications were discontinued. Laboratory
studies revealed hypomagnesemia (1.32 mg/dl), for
which intravenous MgS04 was administered. Local treat-
ment included Vaseline gauze dressings that were changed
once a day.
On the second day of admission, the patient's tempera-
ture began to rise. Complete blood count revealed leuko-
penia of 2,300 mg/dl. Incisional punch biopsy
demonstrated widespread full-thickness epidermal necro-
sis (Fig. 3). The dermis was devoid of inflammatory cells.
Histopathological findings were compatible with the
diagnosis of TEN. The patient was referred to our intensive
care unit (ICU), and treatment with intravenous immu-
noglobulins (IVIG) was initiated (0.5 g/kg daily for 4
Clinical manifestation of TEN, demonstrating widespread epi- demiolysis affecting bilateral breast, lower abdomen, and  anteromedial aspect of the right arm Figure 1
Clinical manifestation of TEN, demonstrating wide-
spread epidemiolysis affecting bilateral breast, lower 
abdomen, and anteromedial aspect of the right arm. 
The central anterior trunk is not affected.
Closer view demonstrating the epidermolysis in the right  breast Figure 2
Closer view demonstrating the epidermolysis in the 
right breast.
Skin biopsy demonstrating full thickness epidermal necrosis Figure 3
Skin biopsy demonstrating full thickness epidermal 
necrosis. The dermis is devoid of inflammatory cells. (H&E, 
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days, the total daily dose of IVIG was 40 grams). The
hemodynamic instability was successfully treated with
inotropic agents and mechanical ventilation.
Blood culture results, obtained during the patient's hospi-
talization in the ICU, were positive for Klebsiella pneumo-
niae, Proteus mirabilis, Enterobacter, Enterococcus and
Pseudomonas aeruginosa. Antibiotic treatment included
vancomycin, levofloxacin, ciprofloxacin, ampicillin sul-
bactam, piperacillin tazobactam, and amikacin sulfate.
The clinical course was complicated by adult respiratory
distress syndrome, thrombocytopenia, and hypoglycemic
episodes. Following prolonged ventilation, tracheostomy
was performed. After 42 days in the ICU, the patient was
found to be hemodynamically stable and afebrile, and
was discharged to rehabilitation. Study of the cutaneous
lesions demonstrated re-epithelization with successful
wound healing. Mild pigmentary alterations remained
with no residual scars. Despite the favorable course of
TEN in this case, the patient succumbed to intracranial
hemorrhage 4 months later. This outcome was entirely
unrelated to TEN.
Discussion
TEN is a rare exfoliative disorder with an estimated annual
incidence of 1-2 per million [2]. Reported mortality rates
vary from 20 to 60 percent [3]. The most common cause
of TEN is idiosyncratic drug reaction, although viral, bac-
terial, and fungal infections, as well as immunization,
have been described [3]. The drugs most frequently
involved are nonsteroidal anti-inflammatory agents,
chemotherapeutic agents, antibiotics, and anticonvul-
sants [3,5]. Among the cephalosporins, ceftazidime [6],
cefuroxime [7], cephalexin [7-10], and cephem [11] have
been implicated. To the best of our knowledge, this is the
first reported case of TEN induced by ceftriaxone.
The pathogenesis of TEN is still not fully clear. The wide-
spread epidermal death is thought to be a consequence of
keratinocyte apoptosis [12]. A pivotal role of cytotoxic T
lymphocytes has been suggested [3]. Recent studies indi-
cated that TEN may be an MHC-class -I-restricted specific
drug sensitivity resulting in clonal expansion of CD8+
cytotoxic lymphocytes with potential for cytolysis. The
cytotoxicity is apparently mediated by granzymes (serine
proteinases that are components of cytotoxic cells and
natural killer cell granules) [13].
The clinical course of TEN is characterized by a prodromal
phase with influenza-like symptoms followed by intense
erythema, urticarial plaques, and bullae which progress
over a day or two to a more generalized epidermal slough
[3]. There is often severe involvement of the mucosal sur-
faces that may precede the skin lesions. Functionally,
mucosal involvement might entail impaired alimentation
and higher vulnerability to infections, rendering the prog-
nosis less favorable. As such, the absence of mucosal
involvement in the case presented may have contributed
to her favorable outcome. Progressive neutropenia and
thrombocytopenia may develop within a few days and,
together with septic complications, may lead to multi-
organ failure and death. Apart from prompt withdrawal of
the causative drug and rapid initiation of supportive care,
strict therapeutic guidelines are still lacking. The benefit of
individual treatment options is a matter of debate, and the
reader is referred to the comprehensive review by Chave et
al. [1]
Despite the controversial efficacy of intravenous immu-
noglobulins and corticosteroids, our patient was treated
with both. We do not know, however, which agent was
responsible for her clinical improvement.
Conclusion
TEN is an acute, life-threatening, exfoliative disorder with
a high mortality rate. High clinical suspicion, prompt rec-
ognition, and initiation of supportive care is mandatory.
Thorough investigation of the pathogenetic mechanisms
is fundamental. Optimal treatment guidelines are still
unavailable. Multi-institutional collaborative efforts to
develop better treatment strategies are warranted.
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